tetano
Editor, Senior Moderator
JMIR Public Health Surveill. 2020 Apr 6;6(2):e18887. doi: 10.2196/18887.
Conducting Clinical Research During the COVID-19 Pandemic: Investigator and Participant Perspectives.
Padala PR[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Jendro AM[SUP]1[/SUP], Padala KP[SUP]1,[/SUP][SUP]3[/SUP].
Author information
Abstract
As the medical landscape changes daily with the coronavirus disease (COVID-19) pandemic, clinical researchers are caught off-guard and are forced to make decisions on research visits in their ongoing clinical trials. Although there is some guidance from local and national organizations, the principal investigator (PI) is ultimately responsible for determining the risk-benefit ratio of conducting, rescheduling, or cancelling each research visit. The PI should take into consideration the ethical principles of research, local/national guidance, the community risk of the pandemic in their locale, staffing strain, and the risk involved to each participant, to ultimately decide on the course of action. While balancing the rights and protection of the human subject, we seldom examine patients' views and opinions about their scheduled research visit(s). This article discusses the ethical principles of beneficence and autonomy in helping the decision-making process. We discuss ways to weigh-in local and national guidance, staffing strain, and institutional support into the decision-making process and outline potential changes needed for regulatory bodies depending on the decision. Further, we discuss the need to weigh-in the individual risk-benefit ratio for each participant and present a decision tree to navigate this complex process. Finally, we examine participant and caregiver perspectives on their fears, sense of preparedness, and factors that they consider before deciding whether to keep or postpone the research appointments. This entry also provides PIs ways to support their research participants in both scenarios, including provision of psychological support.
?Prasad R Padala, Ashlyn M Jendro, Kalpana P Padala. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 06.04.2020.
KEYWORDS:
COVID-19; clinical research; ethics; infectious disease; outbreak; pandemic; public health
PMID:32250281DOI:10.2196/18887
Free full text
Conducting Clinical Research During the COVID-19 Pandemic: Investigator and Participant Perspectives.
Padala PR[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Jendro AM[SUP]1[/SUP], Padala KP[SUP]1,[/SUP][SUP]3[/SUP].
Author information
Abstract
As the medical landscape changes daily with the coronavirus disease (COVID-19) pandemic, clinical researchers are caught off-guard and are forced to make decisions on research visits in their ongoing clinical trials. Although there is some guidance from local and national organizations, the principal investigator (PI) is ultimately responsible for determining the risk-benefit ratio of conducting, rescheduling, or cancelling each research visit. The PI should take into consideration the ethical principles of research, local/national guidance, the community risk of the pandemic in their locale, staffing strain, and the risk involved to each participant, to ultimately decide on the course of action. While balancing the rights and protection of the human subject, we seldom examine patients' views and opinions about their scheduled research visit(s). This article discusses the ethical principles of beneficence and autonomy in helping the decision-making process. We discuss ways to weigh-in local and national guidance, staffing strain, and institutional support into the decision-making process and outline potential changes needed for regulatory bodies depending on the decision. Further, we discuss the need to weigh-in the individual risk-benefit ratio for each participant and present a decision tree to navigate this complex process. Finally, we examine participant and caregiver perspectives on their fears, sense of preparedness, and factors that they consider before deciding whether to keep or postpone the research appointments. This entry also provides PIs ways to support their research participants in both scenarios, including provision of psychological support.
?Prasad R Padala, Ashlyn M Jendro, Kalpana P Padala. Originally published in JMIR Public Health and Surveillance (http://publichealth.jmir.org), 06.04.2020.
KEYWORDS:
COVID-19; clinical research; ethics; infectious disease; outbreak; pandemic; public health
PMID:32250281DOI:10.2196/18887
Free full text